| Title: | The Common PKD1 p.(Ile3167Phe) Variant Is Hypomorphic and Associated with Very Early Onset, Biallelic Polycystic Kidney Disease |
| Journal: | Human Mutation |
| Published: | 28 Jul 2023 |
| DOI: | https://doi.org/10.1155/2023/5597005 |
| URL: | https://downloads.hindawi.com/journals/humu/2023/5597005.pdf |
Publication 7709
WARNING: the interactive features of this website use CSS3, which your browser does not support. To use the full features of this website, please update your browser.
Abstract
Biallelic PKD1 variants, including hypomorphic variants, can cause very early onset polycystic kidney disease (VEO-PKD). A family with unexplained recurrent VEO-PKD and neonatal demise in one dizygotic twin was referred for clinical testing. Further individuals with the putative hypomorphic PKD1 variant, p.(Ile3167Phe), were identified from the UK 100,000 genomes project (100 K), UK Biobank (UKBB), and a review of the literature. We identified a likely pathogenic PKD1 missense paternal variant and the putative hypomorphic PKD1 variant from the unaffected mother in the deceased twin but only the paternal PKD1 variant in the surviving dizygotic twin. Analysis of 100 K cases identified a second family with two siblings with similar biallelic inheritance who presented at birth with VEO-PKD and reached kidney failure in their teens unlike other affected relatives. Finally, a survey of 618 UKBB cases confirmed that adult patients monoallelic for PKD1 p.(Ile3167Phe) had normal kidney function. Our data reveals that p.(Ile3167Phe) is the second most common PKD1 hypomorphic variant identified and is neutral in heterozygosity but is associated with VEO-PKD when inherited in trans with a pathogenic PKD1 variant. Care should be taken to ensure that it is not automatically filtered from sequence data for VEO cases.13 Authors
- Miranda Durkie
- Christopher M. Watson
- Peter Winship
- Anne-Cecile Hogg
- Rodney Nyanhete
- Sharon Cooley
- Manoj K. Valluru
- Charles Shaw-Smith
- Coralie Bingham
- Mark Gilchrist
- Janna Kenny
- Genomics England Research Consortium
- Albert C. M. Ong
Enabling scientific discoveries that improve human health